Austrian breast cancer screening a success:
This article was originally published in Clinica
Executive Summary
The steady fall in the number of women dying from breast cancer in Austria over the past 10 years is a result of effective early detection and improved therapy, says the Vienna regional sickness fund (WGKK). Vienna introduced screening of women between the ages of 50-70 under the auspices of the WGKK, the Viennese doctors' chamber and the Vienna council, in 2001. The screening added to earlier measures that saw the three-year survival rate, which was some 15% in the 1970s, reach 61% by the end of the 1990's, it claims. The five-year rate has also risen from 10-40% over the same period. 18 Viennese women contract breast cancer and eight die from the disease per week, on average.
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.